Thymosin β4

Brevis descriptio:


  • Product nomen:Thymosin β4
  • Cas No:77591-33-4
  • Formulae hypotheticae:C212H350N56O78S
  • Pondus hypotheticum:4963.51 g/mol
  • Sequentia:Ac-Ser-Asp-Lys Pro Asp-Met Ala-Glu-Ile-Glu-Lys Phe Asp-Lys Ser Lys Leu-Lys Lys Thr-Glu-Thr-Gln-Glu- Lys-Asn Pro-Leu-Pro Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH sal acetatum
  • Aspectus:cerussa
  • Applicatio:Vulnus sanitatem
  • Sarcina:Secundum Lorem scriptor requisitis
  • Product Detail

    Product Tags

    Keywords

    • Thymosin beta 4 acetate
    • CAS# 77591-33-4
    • princeps qualitas cum competitive pretium

    Velox Details

    • ProName: Thymosin beta 4
    • CasNo: 77591-33-4
    • Formulae hypotheticae: C212H350N56O78S
    • Aspectus: cerussa
    • Applicationem: Vulnus sanitatem
    • DeliveryTime: promptum sit amet
    • Sarcina: secundum elit scriptor requisitis
    • Portus: Shenzhen
    • ProductionCapacity: II Kilogram/mense
    • Puritas: 98%
    • Repono: 2~8℃. tuta lux
    • Transportatio: per aerem
    • LimitNum: 1 Gram

    Superioritas

     

    professional peptide fabrica in Sina.
    princeps qualis est gmp gradus
    magnis auctoribus pretium
    nostra producta complectitur: mole generica apis peptidis, peptide medicatura, consuetudo peptides et peptides veterinarii.

     

    Singula

    Formulae hypotheticae

    C212H350N56O78S

    Relativum Missae Molecularis

    4963.51 g/mol

    CAS-Number

    77591-33-4

    Long-term PRAECLUSIO

    -20 ± 5°C

    Sequentia

    Ac-Ser-Asp-Lys Pro Asp-Met Ala-Glu-Ile-Glu-Lys Phe Asp-Lys Ser Lys Leu-Lys Lys Thr-Glu-Thr-Gln-Glu- Lys-Asn

    Pro-Leu-Pro Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH sal acetatum

    Agri applicationis:

    Vulnus sanitatem

    Substantia activa

    Thymosin β4 est 43 peptidis acidum amino, quod principale pro Gactin sequestratione peptidis intracellulare censetur.

    Thymosin extracellulare, β4 processibus physiologicis sicut angiogenesis conferre potest;

    vulnus sanationis, et inflammationis moderatio.

     

    Societas Profile:

    societas nomen:Shenzhen JYMed Technologia Co.,Ltd.
    Annus Constitutus: 2009
    Capital: 89.5 Million RMB
    Acetatum oxytocinum, acetatis vasopressinum, acetatis Desmopressin, acetatis terlipressin, acetatis Caspofungin, micafungin sodium, acetatis eptifibatidis, acetatis bivalirudin TFA, Deslorelini acetatis, acetatis glucagonis, acetatis histrelini, acetatis Caspofunginin, aceta- tis aeteris, acetatis elixatae, acetatis Bivalirudin TFA, deslorelin acetatis, glucagon. Acetate, Goserelin
    Acetate, Argireline Acetate, Metrixyl Acetate, Snap VIII, ....
    Studemus continuas innovationes in nova synthesi technologiae peptide et processu optimizationis, et nostra turma technica supra decennium experientiae in synthesi peptide.JYM feliciter multum submisit.
    of ANDA peptide APIs et producta cum CFDA formata et supra quattuor patentes approbatas habent.
    Nostra planta peptide in Nanjing sita, provincia Jiangsu et facilitatem 30,000 metrorum quadratorum posuit in obsequio cum indice cGMP. Facilitas artificiorum ab clientibus tam domesticis quam internationalibus est audita et inspecta.
    Cum praestantissima qualitate, pretiosissima et validissima subsidia technica, JYM recognitiones non solum acquisivit pro suis Institutis Investigationis et industriarum pharmaceuticae, sed etiam unus factus est ex certissimis praebitoribus peptidum in Sinis. JYM dedicatum est unum esse provisor primarius peptidis mundi in proximo futuro.

  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis